Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Valuation -- Ignore unavailable to you. Want to Upgrade?

To: chirodoc who wrote (1004)	4/20/2000 3:27:00 PM
From: Mike McFarland	Read Replies (2) \| Respond to of 52153

<biotech=a risky endeavor> huh? <rant> Microsoft is down 30% YTD, so how is it that in the same article we see biotech tagged with "riskiness". I've noticed that just about every time anything is said about biotech these past few weeks, it is catagorized as being a "risky" sector, or a sector for "gamblers". What a crock, the whole market is risky--I especially love the bullshit cliches like "dollar cost averaging" and "diversification" etc etc--that might help smooth out the bumps, but it isn't going to help a bit if you suck. Buy a freaking index, or pick your stocks. Anything in between is giving the "industry" a cut of the action--why do that? I'll bet 90% of mutual fund "investors" don't know what the hell their funds own (after msft, csco, intc of course--heheh)--"investing" in Microsoft. What does MSFT do with their earnings--in part they buy small upstart companies, and lots of treasureies I suppose, I'd rather cut out the middle man here too. And another thing... If I hear McCamant drop Imclone and Isis again next time he speaks I am going to freakin' spew. Doesn't this guy have any new ideas? </rant>